Nav: Home

New options for treating autism

November 18, 2015

The researcher Olga Peñagarikano, a Ramón y Cajal researcher in the Department of Pharmacology at the UPV/EHU's Faculty of Medicine, and who has broad experience in the study of the neurobiological causes of autism and intervention in the oxytocin system as a potential treatment for this condition, has contributed towards a piece of research carried out by a team at the University of California, Irvine.

The Autism Spectrum Disorder (ASD) is mainly characterised by a deficit in social behaviour. Oxytocin, a natural hormone produced by the brain, is involved in social behaviour. There have been some clinical trials with humans in which it has been demonstrated that when the amount of oxytocin is increased, there are certain aspects that improve in social interactions. "Today there is as yet no treatment in autism to improve social behaviour, but one of the most promising therapies for ASD is intervention in the oxytocin system," explained the researcher.

It is believed that at least some of the patients with ASD could have a dysfunction in this system. In fact, in another recent publication, the researcher showed that a mouse autism model displayed reduced levels of oxytocin in the brain and that the administering of the hormone improved social behaviour. To do this, she built a viral vector -- a virus that has been modified so that it is not pathogenic, in other words, it does not cause any illness -- to transfer an artificial receptor to the neurons that produce oxytocin in the mouse. This technique, known as DREADD (Designer Receptors Exclusively Activated by Designer Drugs), is a widely used technique in the study of neuronal circuits: it consists of transferring an artificial receptor to the relevant neurons, which will be activated or disabled exclusively through the administering of a specific drug to study the effect.

Anandamide increases the preference for interacting socially

Dr Daniele Piomelli, a researcher at the University of California and expert in endocannabinoids, contacted Peñagarikano to be able to use the vector developed by this Basque researcher in the DREADD technique in a study that has served to demonstrate that the release of oxytocin leads to an increase in the production of anandamide (an endogenous substance produced by the body and which acts on the cannabinoid receptors, the same receptors on which cannabis acts). "My involvement in this work was to share the viral vector needed for the DREADD technique and to supervise its use and offer advice to ensure that it was used successfully," explained Peñagarikano.

The results obtained in the research suggest that one of the mechanisms by which oxytocin causes interpersonal relations to be perceived as pleasant could be through the release of anandamide. When the amount of anandamide was increased, the mice displayed a greater preference for interacting socially. When the oxytocin system is activated, both pharmacologically and through the DREADD technique, an increase in anandamide production occurs. Oxytocin is known to interact with other neurotransmitters in this system, such as serotonin and dopamine. This piece of work "reveals a new component in the system," concluded Peñagarikano, "which could have implications when it comes to developing drugs for conditions affected by impairments in social behaviour, such as autism, and based on the modulation of this circuit".
-end-
Additional information

Dr Olga Peñagarikano (Tolosa, Basque Country, 1974) recently (2015) joined the Department of Pharmacology at the UPV/EHU Faculty of Medicine as a Ramón y Cajal researcher. She spent 6 years working at the University of California, Los Angeles (UCLA) as a post-doctoral researcher. Her work focusses on studying the neurobiological causes of autism in order to come up with treatments, and right now she is exploring intervention in the oxytocin system as a potential treatment for autism in a project being funded by the Brain and Behavior Research Foundation in the United States (formerly NARSAD).

Bibliographical reference

Don Wei, DaYeon Lee, Conor D. Cox, Carley A. Karsten, Olga Peñagarikano, Daniel H. Geschwind, Christine M. Gall, Daniele Piomelli. "Endocannabinoid signaling mediates oxytocin-driven social reward". PNAS. Published online before print on Oct. 26, 2015.

University of the Basque Country

Related Autism Articles:

Adulthood with autism
The independence that comes with growing up can be scary for any teenager, but for young adults with autism spectrum disorder and their caregivers, the transition from adolescence to adulthood can seem particularly daunting.
Brain protein mutation from child with autism causes autism-like behavioral change in mice
A de novo gene mutation that encodes a brain protein in a child with autism has been placed into the brains of mice.
Autism and theory of mind
Theory of mind, or the ability to represent other people's minds as distinct from one's own, can be difficult for people with autism.
Potential biomarker for autism
A study of young children with autism spectrum disorder published in JNeurosci reveals altered brain waves compared to typically developing children during a motor control task.
Autism and the smell of fear
Autism typically involves the inability to read social cues. We most often associate this with visual difficulty in interpreting facial expression, but new research at the Weizmann Institute of Science suggests that the sense of smell may also play a central role in autism.
Autism often associated with multiple new mutations
Most autism cases are in families with no previous history of the disorder.
State laws requiring autism coverage by private insurers led to increases in autism care
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health has found that the enactment of state laws mandating coverage of autism spectrum disorder (ASD) was followed by sizable increases in insurer-covered ASD care and associated spending.
Autism's gender patterns
Having one child with autism is a well-known risk factor for having another one with the same disorder, but whether and how a sibling's gender influences this risk has remained largely unknown.
Pinpointing the origins of autism
The origins of autism remain mysterious. What areas of the brain are involved, and when do the first signs appear?
Genes, ozone, and autism
Exposure to ozone in the environment puts individuals with high levels of genetic variation at an even higher risk for developing autism than would be expected just by adding the two risk factors together, a new analysis shows.
More Autism News and Autism Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.